Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes (2018 - 2026)

Arcturus Therapeutics Holdings has reported Other Working Capital Changes for 9 years, with the latest figure at -$809000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 32.75% year-over-year to -$809000.0; the trailing twelve-month figure through Mar 2026 stood at -$4.6 million (up 91.5% YoY), and the FY2025 full-year result was -$5.0 million, up 90.94% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$809000.0, down from $16.1 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $34.5 million in Q3 2024, with the low at -$56.1 million in Q4 2024.
• Historically, Other Working Capital Changes has averaged -$3.4 million across 5 years, with a median of -$1.0 million in 2023.
• The largest YoY upside for Other Working Capital Changes was 731.14% in 2024 against a maximum downside of 9116.75% in 2024.
• Arcturus Therapeutics Holdings' Other Working Capital Changes stood at $1.7 million in 2022, then tumbled by 135.28% to -$609000.0 in 2023, then sank by 9116.75% to -$56.1 million in 2024, then surged by 128.63% to $16.1 million in 2025, then slumped by 105.03% to -$809000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$809000.0 (Q1 2026), $16.1 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.